That's what I thought. But if US FDA approval is required for BK to seek their approvals, we have accomplished nothing without US trials, assuming none of the overseas trials count for the FDA process.
It seems to be a catch-22, and the only way out would seem to be US trials, if you are correct.
I emailed Joe. Will see if I get a response.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links